SCHEMBL11854079

SCHEMBL11854079

CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 2/20 0.59
▸ TSHR P16473 1/20 0.45
▸ ALOX15 P16050 6/20 0.44
▸ ALOX12 P18054 5/20 0.44
▸ HSD17B10 Q99714 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ RECQL P46063 3/20 0.44
▸ HIF1A Q16665 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ ESR1 P03372 2/20 0.44
▸ TP53 P04637 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ IARS1 P41252 2/20 0.44
▸ USP2 O75604 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11853292 0.92 LCK (0.49) LCKALOX15ALOX12HSD17B10ALDH1A1
SCHEMBL11859267 0.88 ACE (0.55) LCKALOX15ALOX12HSD17B10ALDH1A1
SCHEMBL11859253 0.88 ACE (0.55) LCKALOX15ALOX12HSD17B10ALDH1A1
SCHEMBL11858061 0.87 ACE (0.48) LCKTSHRPOLBEGFRMME
SCHEMBL27338709 0.87 TSHR (0.59) TSHRHSD17B10ALDH1A1CYP2C9CYP2C19
SCHEMBL27338457 0.85 LCK (0.64) LCKTSHRALOX15ALOX12HSD17B10
SCHEMBL11849660 0.84 LCK (0.65) LCKTSHRALOX15HSD17B10ALDH1A1
SCHEMBL4127653 0.83 LCK (0.56) LCKTSHRALOX15HSD17B10ALDH1A1
SCHEMBL4127657 0.83 LCK (0.56) LCKTSHRALOX15HSD17B10ALDH1A1
Hydrochloric Acid SCHEMBL11684930 0.83 LCK (0.64) LCKTSHRALOX15HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3939253-A Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease INTERX RESEARCH CORPORATION (US) 1976-02-17 — — US disclosed
Send feedback